| 000 | 01876 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513140032.0 | ||
| 264 | 0 | _c19980409 | |
| 008 | 199804s 0 0 fre d | ||
| 022 | _a0003-4401 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMinkov, N | |
| 245 | 0 | 0 |
_a[Late results of the complex treatment of primary kidney neoplasm in children]. _h[electronic resource] |
| 260 |
_bAnnales d'urologie _c1997 |
||
| 300 |
_a344-7 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDactinomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aLiver Neoplasms _xsecondary |
| 650 | 0 | 4 |
_aLung Neoplasms _xsecondary |
| 650 | 0 | 4 | _aLymph Node Excision |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aSplenic Neoplasms _xsecondary |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 650 | 0 | 4 |
_aWilms Tumor _xdrug therapy |
| 700 | 1 | _aChristosova, I | |
| 700 | 1 | _aKiourktchieva, S | |
| 700 | 1 | _aRousseva, T | |
| 773 | 0 |
_tAnnales d'urologie _gvol. 31 _gno. 6-7 _gp. 344-7 |
|
| 999 |
_c9477052 _d9477052 |
||